Telethon Kids Institute, The University of Western Australia, Perth, Western Australia, Australia.
HudsonAlpha Institute for Biotechnology, Huntsville, Alabama.
Am J Med Genet A. 2020 May;182(5):1217-1222. doi: 10.1002/ajmg.a.61504. Epub 2020 Feb 8.
Pathogenic variants in the cyclin-dependent kinase-like 5 (CDKL5) gene cause the neurodevelopmental disorder, the CDKL5 deficiency disorder. Reports of individuals with pathogenic variants in CDKL5 without seizures are exceedingly rare, and in-depth analyses of their variants have been lacking. Whole-genome sequencing was performed on a 29-year-old female with mild intellectual disability who, in the absence of overt seizures, presented with multiple episodes of altered mental status over a 24-year period. Clinical history was supplemented by a parent completed questionnaire from the International CDKL5 Disorder Database. We identified a de novo heterozygous variant in CDKL5 (NM_003159.2:c.645T>A;p.Ser215Arg). In-depth computational analysis performed to predict the impact of the variant on protein structure and function demonstrated that the variant was likely pathogenic. In this light, cell-based studies showed that the S215R substitution causes a marked reduction in CDKL5 kinase activity. Similarities between our case and one previously reported case are striking. These cases, both without seizures but with apparent behavioral symptomatology, together question whether seizures are mandatory in this neurodevelopmental disorder.
CDKL5 基因中的致病性变异会导致神经发育障碍,即 CDKL5 缺乏症。报道称,患有 CDKL5 致病性变异但无癫痫的个体极为罕见,且对其变异的深入分析也很缺乏。对一名 29 岁的女性进行了全基因组测序,该女性智力轻度受损,在 24 年期间多次出现精神状态改变,无明显癫痫发作。临床病史由来自国际 CDKL5 疾病数据库的家长完成问卷进行补充。我们在 CDKL5 中发现了一个杂合的新生变异(NM_003159.2:c.645T>A;p.Ser215Arg)。为预测变异对蛋白质结构和功能的影响而进行的深入计算分析表明,该变异可能是致病性的。有鉴于此,基于细胞的研究表明,S215R 取代会导致 CDKL5 激酶活性明显降低。我们的病例与之前报道的一个病例之间有许多相似之处。这些病例均无癫痫发作,但有明显的行为症状,这使得人们对这种神经发育障碍是否必须有癫痫发作提出了质疑。